➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
McKinsey
Johnson and Johnson
Moodys
Colorcon

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Patent: 9,247,960

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,247,960
Title:Recovery and processing of human embryos formed in vivo
Abstract: Among other things, uterine lavage is performed to withdraw at least 50% of in vivo fertilized preimplantation embryos produced after superovulation of a woman and artificial insemination using sperm of her sexual partner. After genetic diagnosis or sex determination or gene therapy, or any combination of any two or more of them, of the recovered embryos and selection of at least one of the embryos to be implanted, the selected embryos are returned to the woman for implantation in her uterus.
Inventor(s): Carson; Sandra Ann (Providence, RI), Buster; John E. (Providence, RI)
Assignee: Previvo Genetics, LLC (Piedmont, CA)
Application Number:14/250,240
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,247,960
Patent Claims:see list of patent claims

Details for Patent 9,247,960

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ferring Pharmaceuticals Inc. MENOPUR menotropins KIT 021663 1 2004-10-29   Start Trial Previvo Genetics, LLC (Piedmont, CA) 2031-12-22 search
Ferring MENOPUR menotropins (fsh;lh) INJECTABLE;SUBCUTANEOUS 021663 001 2006-03-20   Start Trial Previvo Genetics, LLC (Piedmont, CA) 2031-12-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Moodys
Mallinckrodt
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.